PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Aspetar Orthopedic and Sports Medicine Hospital, Doha, Qatar.\', \'Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar.\', \'Department of Pharmaceutical Sciences, College of Pharmacy and Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.\', \'Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar; Office of the Vice President for Research and Graduate Studies, Qatar University, Doha, Qatar.\', \'Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, Qatar; Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0753-3322(21)01169-010.1016/j.biopha.2021.112385
?:doi
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 34915673
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all